Ophthotech Corporation is a privately held, clinical-stage biotechnology company located in Princeton, NJ and New York, NY.
Our experience and expertise with back of the eye diseases enables us to concentrate on developing and commercializing therapies for both dry and wet Age-Related Macular Degeneration (AMD) in an accelerated manner.